2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line

Biochemical and Biophysical Research Communications

Volumn 296, Issue 3, 2002, Pages 651-656

  Murayama, Tsugiya ^a   Inoue, Masao ^b   Nomura, Taisei ^c   Mori, Seiichiro ^a   Eizuru, Yoshito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; AhR; ARNT; Cytomegalovirus; Cytopathic effects; Fibroblast cell; MRC 5; Opportunistic diseases; TCDD; UL54

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARRIER PROTEIN; DNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; FIBROBLAST CULTURE; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS ACTIVATION; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FIBROBLASTS; HUMANS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0036382930     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00921-X     Document Type: Article

References (29)

1. A. Poland, J.C. Knutson, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity, Annu. Rev. Pharmacol. Toxicol. 22 (1982) 517-554.
2. S.H. Safe, Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans, Annu. Rev. Pharmacol. Toxicol. 26 (1986) 371-399.
3. S.H. Safe, Development of bioassays and approaches for the risk assessment of 2,2,7,8-tetrachlorodibennzo-p-dioxin related compound, Environ. Health Perspect. 101 (1993) 317-325.
4. G. Clark, A. Tritscher, D. Bell, G. Lucier, Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs, Environ. Health Perspect. 98 (1992) 125-132.
5. N.I. Kerkvliet, G.R. Bruelson, Immunotoxicity of TCDD, in: J.H. Dean, M.L. Luster, A.E. Munson, I. Kimber (Eds.), Immunotoxicology and Immunopharmacology, Raven Press, New York, 1995, pp. 97-142.
6. J.E. Thigpen, R.E. Faith, E.E. Mcconnel, J.E. Moore, Increased susceptibility to bacterial infection as a sequel of exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Infect. Immunity 12 (1975) 1319-1324.
7. G.R. Burleson, H. Lebrec, Y.G. Yang, J.D. Ibanes, K.N. Pennington, L.S. Birnbaum, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice, Fundam. Appl. Toxicol. 29 (1996) 40-47.
8. S. Gollapudi, C.H. Kim, A. Patel, R. Sindhu, S. Gupta, Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-κB activity and production of tumor necrosis factor-α, Biochem. Biophys. Res. Commun. 226 (1996) 889-894.
9. W.J. Britt, C.A. Alford, Cytomegalovirus, in: B.N. Fields, D.M. Knipe, P.M. Howley (Eds.), Virology, Lippincott-Raven, Philadelphia, 1990, pp. 2493-2523.
10. J.D. Meyers, Infection in bone marrow transplant recipients, Am. J. Med. 81 (1986) 27-38.
11. J.P. Maciejewski, E.E. Bruening, R.E. Donahue, E.B. Mocarski, N.S. Young, S.C. St. Jeor, Infection of hematopoietic progenitor cells by human cytomegalovirus, Blood 80 (1992) 170-178.
12. E.J. Minton, C. Tysoe, J.H. Sinclair, J.G. Sissons, Human cytomegalovirus infection of monocyte/macrophage lineage in bone marrow, J. Virol. 68 (1994) 4017-4021.
13. J.G. Vos, J.G. Kreeftenberg, H.W.B. Engel, A. Minderhoud, N. Van, L.M. Jansen, Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression and decreased resistance to infection: endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment, Toxicology 9 (1978) 75-86.
14. Y.G. Yang, H. Lebrec, G.R. Burleson, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on pulmonary influenza virus titer and natural killer (NK) activity in rats, Fundam. Appl. Toxicol. 23 (1994) 125-131.
15. R.V. House, L.D. Lauer, M.J. Murray, P.T. Thomas, J.P. Ehrlich, G.R. Burleson, J.H. Dean, Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Toxicol. Environ. Health 31 (1990) 203-215.
16. J. Garssen, D.V.H. Van, K.A. De, W. Goettsch, J. Dormans, C.A. Bruggeman, A.D.M.E. Osterhaus, L.H. Van, A rat cytomegalovirus infection model as a tool for immunotoxicity testing, Eur. J. Pharmacol. (Environ. Toxic.) 292 (1995) 223-231.
17. C.A. Bruggeman, H. Meijer, F. Bosman, B.C.P.A. Van, Biology of rat cytomegalovirus infection, Intervirology 24 (1985) 1-9.
18. P.S. Ross, H.V. Loveren, S.R.L. De, D.V.H. Van, K.A. De, H.H. Timmerman, B.R. Van, A. Brouwer, J.G. Vos, A.D.M.E. Osterhous, Host resistance to rat cytomegalovirus (RCMV) and immune function in adult PVG rats fed herring from the contaminated Baltic Sea, Arch. Toxicol. 70 (1996) 661-671.
19. T. Furukawa, A. Fioretti, S. Plotkin, Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication, J. Virol. 11 (1973) 991-997.
20. B.B. Wentworth, L. French, Plaque assay of cytomegalovirus strain of human origin, Proc. Soc. Exp. Biol. Med. 135 (1970) 253-258.
21. J.P. Jacobs, C.M. Jones, J.P. Belle, Characteristics of a diploid cell designated MRC-5, Nature 227 (1970) 168-173.
22. T. Furukawa, F. Jisaki, D. Sakamuro, T. Takegami, T. Murayama, Detection of human cytomegalovirus genome in uterus tissue, Arch. Virol. 135 (1994) 265-277.
23. T. Murayama, K. Kuno, F. Jisaki, M. Obuchi, D. Sakamuro, T. Furukawa, N. Mukaida, K. Matsushima, Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8, J. Virol. 68 (1994) 7582-7585.
24. K. Harada, Y. Eizuru, Y. Isashiki, S. Ihara, Y. Minamishima, Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir, Arch. Virol. 142 (1997) 215-225.
25. P. Chomczynski, N. Sacchi, Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
26. E.C.B. Jorgensen, H. Autrup, Autoregulation of human CYP1A1 gene promotor activity in HepG2 and MCF-7 cells, Carcinogenesis 17 (1996) 435-441.
27. J.M. DeMarchi, A.S. Kaplan, Physiological state of human embryonic lung cells affects their response to human cytomegalovirus, J. Virol. 23 (1977) 126-132.
28. J.C. Powlands, J.A. Gustafsson, Aryl hydrocarbon receptor-mediated signal transduction, Crit. Rev. Toxicol. 27 (1997) 109-134.
29. R. Stone, Dioxin report faces scientific gauntlet, Science 265 (1994) 1650.